Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

Tillgänglig från:

Hospira Australia Pty Ltd

INN (International namn):

Vinorelbine tartrate

Läkemedelsform:

Injection

Sammansättning:

Excipient Ingredients: water for injections

Administreringssätt:

Intravenous

Enheter i paketet:

1 x 1 mL vial

Klass:

Medicine Listed (Export Only)

Receptbelagda typ:

Not scheduled. Not considered by committee

Terapeutiska indikationer:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

Produktsammanfattning:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Bemyndigande status:

Listed (Export Only)

Tillstånd datum:

2008-05-05